Press release
Polyclonal Antibodies Market on Track for Strong Growth, Estimated to Grow at 6.9% CAGR Through 2029
Polyclonal Antibodies Market
What Is the Expected CAGR for the Polyclonal Antibodies Market Through 2025?
In recent times, the size of the polyclonal antibodies market has shown steady growth. It's projected to rise from $1.41 billion in 2024 to reach $1.48 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.0%. The growth during the historical period can be credited to the demand for biomedical research, an upsurge in diagnostic uses, a rise in chronic diseases, and a vast array of applications.
What's the Projected Size of the Global Polyclonal Antibodies Market by 2029?
The market for polyclonal antibodies is poised for significant expansion in the upcoming years, anticipated to attain a value of "$1.94 billion in 2029" with a CAGR of 6.9%. This projected growth within the forecast period is largely due to advancements in diagnostic technologies and treatments, a surge in infectious diseases, increased funding for research, and collaboration and partnerships. Key trends within this forecast period encompass progress in antibody engineering, its escalating involvement in cancer immunotherapy, the emergence of biosimilar polyclonal antibodies, its utilisation in neurological disorders, and advancements in regulatory and compliance measures.
View the full report here:
https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report
Top Growth Drivers in the Polyclonal Antibodies Industry: What's Accelerating the Market?
The rise in cancer cases is anticipated to fuel the expansion of the polyclonal antibodies market. In cancer research and treatment, polyclonal antibodies are employed for biomarker discovery, immunohistochemistry, targeted therapy, and immunotherapy, enhancing cancer diagnosis, treatment, and patient outcomes. The surge in cancer patients boosts the polyclonal antibodies market growth. For example, Cancer Australia, an Australian organization dedicated to aiding cancer patients and raising disease awareness, predicts 2,572 new cases of stomach cancer in Australia in 2022 (1,661 cases in men and 911 in women) as of September 2022. The chance of getting stomach cancer by the age of 85 in 2022 is 1 in 114 (0.87%) overall, which breaks down to 1 in 1.1 (87%) for men and 1 in 167 (0.60%) for women. Therefore, the rising prevalence of cancer instigates the growth of the polyclonal antibodies market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10790&type=smp
What Are the Key Trends Driving Polyclonal Antibodies Market Growth?
The primary emerging patterns in the polyclonal antibodies sector involve intensive research and development. To enhance their examination abilities and maintain their market position, key businesses in the field of polyclonal antibodies are heavily focusing on this aspect. As an example, in July 2022, GigaGen Inc., a biotech firm from the United States, publicized a research piece named 'GMP manufacturing and IND-enabling studies of a recombinant hyperimmune globulin targeting SARS-CoV-2,' featured in the globally accredited journal, Pathogens. The research article unveiled its recombinant polyclonal product, GIGA-2050, which targets SARS-CoV-2. It also presented the GMP (good manufacturing practice) production and IND (Investigational Novel Drug)-oriented studies of its innovative category of medicinal products, notably recombinant polyclonal antibodies. GIGA-2050 possesses more than 12,000 antibodies sourced from a single master cell bank (MCB). Prior to GIGA-2050, the production of relatively smaller recombinant antibody mixtures often required building separate MCBs for various monoclonal antibodies and then amalgamating these MCBs before production.
What Are the Main Segments in the Polyclonal Antibodies Market?
The polyclonal antibodies market covered in this report is segmented -
1) By Product Type: Primary Antibody, Secondary Antibody
2) By Source: Rabbits, Goats, Sheep, Other Sources
3) By Application: Research, Diagnostics, Therapy
4) By End-User: Academic and Research Center , Pharmaceutical and Biotechnology Companies, Diagnostic Centers , Hospitals
Subsegments:
1) By Primary Antibody: Immunoglobulin G (IgG), Immunoglobulin M (IgM), Immunoglobulin A (IgA), Immunoglobulin E (IgE)
2) By Secondary Antibody: Anti-Mouse IgG, Anti-Rabbit IgG, Anti-Goat IgG, Other Secondary Antibodies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10790&type=smp
Which Top Companies are Driving Growth in the Polyclonal Antibodies Market?
Major companies operating in the polyclonal antibodies market include Abcam plc, GenScript Biotech Corporation, Merck KGaA, Thermo Fisher Scientific Inc., Becton dic*kinson and Company, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Creative Diagnostics, Agilent Technologies, Analytik Jena GmbH, Atlas Antibodies, Danaher Corporation, DC Biosciences Ltd., Illumia Inc., ImmonoPresice Antibodies Ltd, Fujirebio, Omega BioTek Inc., Dovetail Genomics LLC, Abnova Corporation, Santa Cruz Biotechnology Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., IGY Life Sciences, Genway Biotech, Good Biotech, Gallus Immunotech Inc., BioGenes GmbH, Capralogics Inc., Bio X Cell
Which Regions Will Dominate the Polyclonal Antibodies Market Through 2029?
North America was the largest region in the polyclonal antibodies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global polyclonal antibodies market size forecast period. The regions covered in the polyclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10790
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polyclonal Antibodies Market on Track for Strong Growth, Estimated to Grow at 6.9% CAGR Through 2029 here
News-ID: 4180490 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Antibodies
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The arthritis monoclonal antibodies…
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights:
• Global & Regional Market Analysis
• Global Multispecific Antibodies Market Opportunity: > USD 40 Billion
• Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion
• Number Of Approved Multispecific Antibodies: 14
• Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight
• Approved Antibodies Dosage & Pricing Insight
• Number Of Multispecific Antibodies: In Clinical Trials: > 900
• Comprehensive Insight On All Antibodies In Clinical Trials By…
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:
• Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms
• Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023)
• Global Bispecific Antibodies Market Size 2023: > USD 8 Billion
• Global Bispecific Antibodies Market Forecast Till 2029
• Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023)
• Approved Bispecific Antibodies Regional Sales (2018 till 2023)
• Clinical and Commercial Insight On Approved…
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
Tetravalent antibodies are designed to engage…
